Filing Details
- Accession Number:
- 0001493152-24-045120
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-13 16:05:16
- Reporting Period:
- 2024-11-13
- Accepted Time:
- 2024-11-13 16:05:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1835022 | Coya Therapeutics Inc. | COYA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2034346 | Arun Swaminathan | 5850 San Felipe St., Suite 500 Houston TX 77057 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2024-11-13 | 5,000 | $7.36 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
